首页 > 最新文献

Therapeutics and Clinical Risk Management最新文献

英文 中文
Impact of Oncology Nursing Interventions on Chemotherapy-Induced Toxicities in Lung Cancer Patients. 肿瘤护理干预对肺癌患者化疗毒性的影响。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-11-06 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S545756
Ya Gao, Mei Guo

Background: Chemotherapy-induced toxicities are a significant challenge in lung cancer treatment, leading to reduced treatment adherence, increased hospital readmissions, and lower quality of life. Oncology nursing plays a vital role in managing these toxicities through early assessment, patient education, and supportive care. This study aimed to evaluate the impact of a structured oncology nursing intervention on the management of chemotherapy-related toxicities in lung cancer patients.

Methods: This retrospective cohort study analyzed 313 patients with pathologically confirmed lung cancer who received first-line chemotherapy at Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, between January 2021 and December 2023. Patients were divided into two groups: the intervention group (n = 148) received comprehensive oncology nursing services, including toxicity education, symptom monitoring via telephone follow-up, early triage of adverse events, and individualized supportive care plans; the control group (n = 165) received standard care. Primary outcomes included the incidence and severity of grade ≥2 chemotherapy toxicities, unscheduled hospital visits, and treatment delays. Secondary outcomes included patient satisfaction and anxiety levels.

Results: The intervention group showed a significantly lower incidence of grade ≥2 neutropenia (18.2% vs 30.3%, P = 0.012), chemotherapy-induced nausea/vomiting (24.3% vs 39.4%, P = 0.006), and unplanned emergency visits (9.5% vs 19.4%, P = 0.018). Treatment delays due to unmanaged toxicity were also reduced (12.8% vs 23.0%, P = 0.021). Additionally, the intervention group reported lower anxiety scores (mean STAI: 34.7 vs 41.3, P < 0.001) and higher satisfaction (8.7 vs 7.4, P < 0.001).

Conclusion: Structured oncology nursing interventions significantly improve the management of chemotherapy-induced toxicities in lung cancer patients, reducing complications, enhancing treatment continuity, and improving psychological well-being.

背景:化疗引起的毒性是肺癌治疗的一个重大挑战,导致治疗依从性降低,再入院率增加,生活质量下降。通过早期评估、患者教育和支持性护理,肿瘤护理在管理这些毒性方面起着至关重要的作用。本研究旨在评估结构化肿瘤护理干预对肺癌患者化疗相关毒性管理的影响。方法:回顾性队列研究分析2021年1月至2023年12月在华中科技大学同济医学院湖北省肿瘤医院接受一线化疗的313例病理证实的肺癌患者。患者分为两组:干预组(148例)接受肿瘤综合护理服务,包括毒性教育、电话随访症状监测、不良事件早期分诊、个体化支持性护理方案;对照组(n = 165)接受标准治疗。主要结局包括≥2级化疗毒性的发生率和严重程度、计划外的医院就诊和治疗延误。次要结局包括患者满意度和焦虑水平。结果:干预组患者≥2级中性粒细胞减少发生率(18.2% vs 30.3%, P = 0.012)、化疗引起的恶心/呕吐发生率(24.3% vs 39.4%, P = 0.006)、计划外急诊发生率(9.5% vs 19.4%, P = 0.018)均显著降低。由于未控制的毒性导致的治疗延误也减少了(12.8% vs 23.0%, P = 0.021)。此外,干预组焦虑得分较低(平均STAI: 34.7比41.3,P < 0.001),满意度较高(8.7比7.4,P < 0.001)。结论:结构化肿瘤护理干预可显著改善肺癌患者化疗毒性的管理,减少并发症,提高治疗的连续性,改善心理健康。
{"title":"Impact of Oncology Nursing Interventions on Chemotherapy-Induced Toxicities in Lung Cancer Patients.","authors":"Ya Gao, Mei Guo","doi":"10.2147/TCRM.S545756","DOIUrl":"10.2147/TCRM.S545756","url":null,"abstract":"<p><strong>Background: </strong>Chemotherapy-induced toxicities are a significant challenge in lung cancer treatment, leading to reduced treatment adherence, increased hospital readmissions, and lower quality of life. Oncology nursing plays a vital role in managing these toxicities through early assessment, patient education, and supportive care. This study aimed to evaluate the impact of a structured oncology nursing intervention on the management of chemotherapy-related toxicities in lung cancer patients.</p><p><strong>Methods: </strong>This retrospective cohort study analyzed 313 patients with pathologically confirmed lung cancer who received first-line chemotherapy at Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, between January 2021 and December 2023. Patients were divided into two groups: the intervention group (n = 148) received comprehensive oncology nursing services, including toxicity education, symptom monitoring via telephone follow-up, early triage of adverse events, and individualized supportive care plans; the control group (n = 165) received standard care. Primary outcomes included the incidence and severity of grade ≥2 chemotherapy toxicities, unscheduled hospital visits, and treatment delays. Secondary outcomes included patient satisfaction and anxiety levels.</p><p><strong>Results: </strong>The intervention group showed a significantly lower incidence of grade ≥2 neutropenia (18.2% vs 30.3%, P = 0.012), chemotherapy-induced nausea/vomiting (24.3% vs 39.4%, P = 0.006), and unplanned emergency visits (9.5% vs 19.4%, P = 0.018). Treatment delays due to unmanaged toxicity were also reduced (12.8% vs 23.0%, P = 0.021). Additionally, the intervention group reported lower anxiety scores (mean STAI: 34.7 vs 41.3, P < 0.001) and higher satisfaction (8.7 vs 7.4, P < 0.001).</p><p><strong>Conclusion: </strong>Structured oncology nursing interventions significantly improve the management of chemotherapy-induced toxicities in lung cancer patients, reducing complications, enhancing treatment continuity, and improving psychological well-being.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1549-1558"},"PeriodicalIF":2.8,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12599214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconciling Methodological Paradigms Toward More Accurate Evaluation of Personalized Traditional Chinese Medicine (TCM) Intervention in Standardized Trials: Introducing the TRIPLE-TCM Trial Framework. 调和方法学范式,以更准确地评估标准化试验中个性化中医干预:引入三中医试验框架。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-11-04 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S557457
Fei-Yi Zhao, Li-Ping Yue, Peijie Xu, Russell Conduit, Wen-Jing Zhang, Yuan Xin Lee, Qiang-Qiang Fu, Chin Moi Chow

Traditional Chinese Medicine (TCM) prioritizes highly individualized diagnosis and treatment, a principle that inherently conflicts with the standardized protocols of explanatory randomized controlled trials (RCTs). While pragmatic RCTs have been proposed to better reflect real-world TCM practice, their reliance on unblinded designs raises concerns about placebo effects and potential confounding biases, particularly for interventions like acupuncture. These methodological tensions highlight the need for innovative trial designs that can preserve TCM's personalized ethos while meeting the rigorous standards of evidence-based research. In response, we propose the T rans-paradigm Randomized-Individualized-Preference-Linked Efficacy/Effectiveness Evaluation for TCM (TRIPLE-TCM) framework-a hybrid trial design integrating explanatory RCTs, pragmatic RCTs, and partially randomized patient preference trials. TRIPLE-TCM employs a five-step procedure: (1) TCM pattern-guided recruitment to ensure diagnostic homogeneity; (2) hybrid randomization accommodating patient preferences; (3) semi-standardized interventions combining fixed core prescriptions with individualized adjustments; (4) a clinician-patient co-assessment model incorporating TCM-specific outcomes and validated biomarkers; and (5) cost-utility analyses to inform policy. This framework aims to balance internal and external validity while maintaining fidelity to TCM theory and clinical practice, providing a methodological bridge for TCM's broader acceptance. Further studies should validate its feasibility, reproducibility, and cross-cultural generalizability across diverse disease contexts and healthcare settings, advancing evidence-based integration of acupuncture and Chinese herbal medicine into global healthcare systems.

中医优先考虑高度个性化的诊断和治疗,这一原则与解释性随机对照试验(RCTs)的标准化方案存在内在冲突。虽然实用的随机对照试验已被提出,以更好地反映现实世界的中医实践,但它们对非盲法设计的依赖引发了对安慰剂效应和潜在混淆偏差的担忧,尤其是对针灸等干预措施。这些方法上的矛盾凸显了创新试验设计的必要性,既要保持中医的个性化精神,又要满足循证研究的严格标准。为此,我们提出了T - trans -paradigm随机-个性化偏好关联中医疗效/有效性评估(TRIPLE-TCM)框架——一种混合试验设计,整合了解释性随机对照试验、实用性随机对照试验和部分随机患者偏好试验。三联中医采用五步流程:(1)中医模式引导招募,确保诊断同质性;(2)适应患者偏好的混合随机化;(3)固定核心处方与个体化调整相结合的半标准化干预措施;(4)结合中医特异性结果和经验证的生物标志物的临床-患者联合评估模型;(5)成本效用分析,为政策提供信息。该框架旨在平衡内部有效性和外部有效性,同时保持对中医理论和临床实践的忠实,为中医更广泛的接受提供方法论桥梁。进一步的研究应验证其可行性、可重复性和跨文化推广性,跨越不同的疾病背景和医疗环境,推动针灸和中草药纳入全球医疗体系的循证整合。
{"title":"Reconciling Methodological Paradigms Toward More Accurate Evaluation of Personalized Traditional Chinese Medicine (TCM) Intervention in Standardized Trials: Introducing the TRIPLE-TCM Trial Framework.","authors":"Fei-Yi Zhao, Li-Ping Yue, Peijie Xu, Russell Conduit, Wen-Jing Zhang, Yuan Xin Lee, Qiang-Qiang Fu, Chin Moi Chow","doi":"10.2147/TCRM.S557457","DOIUrl":"10.2147/TCRM.S557457","url":null,"abstract":"<p><p>Traditional Chinese Medicine (TCM) prioritizes highly individualized diagnosis and treatment, a principle that inherently conflicts with the standardized protocols of explanatory randomized controlled trials (RCTs). While pragmatic RCTs have been proposed to better reflect real-world TCM practice, their reliance on unblinded designs raises concerns about placebo effects and potential confounding biases, particularly for interventions like acupuncture. These methodological tensions highlight the need for innovative trial designs that can preserve TCM's personalized ethos while meeting the rigorous standards of evidence-based research. In response, we propose the <b><i>T</i></b> <i>rans-paradigm <b>R</b>andomized-<b>I</b>ndividualized-<b>P</b>reference-<b>L</b>inked <b>E</b>fficacy/<b>E</b>ffectiveness <b>E</b>valuation for TCM</i> (TRIPLE-TCM) framework-a hybrid trial design integrating explanatory RCTs, pragmatic RCTs, and partially randomized patient preference trials. TRIPLE-TCM employs a five-step procedure: (1) TCM pattern-guided recruitment to ensure diagnostic homogeneity; (2) hybrid randomization accommodating patient preferences; (3) semi-standardized interventions combining fixed core prescriptions with individualized adjustments; (4) a clinician-patient co-assessment model incorporating TCM-specific outcomes and validated biomarkers; and (5) cost-utility analyses to inform policy. This framework aims to balance internal and external validity while maintaining fidelity to TCM theory and clinical practice, providing a methodological bridge for TCM's broader acceptance. Further studies should validate its feasibility, reproducibility, and cross-cultural generalizability across diverse disease contexts and healthcare settings, advancing evidence-based integration of acupuncture and Chinese herbal medicine into global healthcare systems.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1521-1534"},"PeriodicalIF":2.8,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12597255/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145490387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Value of CT Fractional Flow Reserve and Fat Attenuation Index Derived from Coronary CT Angiography for In-Stent Restenosis After Percutaneous Coronary Intervention. 冠状动脉CT血管造影所得CT血流储备分数及脂肪衰减指数对经皮冠状动脉介入术后支架内再狭窄的预测价值。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-11-03 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S554207
Beibei Li, Zhiguo Zhang, Xianglei Wei, Tianzeng Song, Yi Zhao, Wei Wang

Aim: To investigate the predictive value of CT fractional flow reserve (CT-FFR) and fat attenuation index (FAI) based on Coronary CT Angiography (CCTA) for in-stent restenosis (ISR) in patients with CAD after PCI.

Methods: Patients with coronary heart disease who were followed up after coronary stent implantation were retrospectively collected, and clinical data, stent features and imaging characteristics were recorded. The Spearman test was used to analyze the correlation between CT-FFR, FAI and ISR. Univariate and multivariate logistic regression were used to determine the independent influencing factors of ISR, and a nomogram model was constructed.

Results: A total of 378 patients were ultimately included. Among them, there were 120 cases in the ISR group and 258 cases in the non-ISR group. Multivariate analysis revealed that CT-FFR2cm, ΔCT-FFR, FAIlesion, stent length, ΔCT-FFR/length, hyperlipidemia, and lipoprotein(a) are independent predictors of ISR. The ROC analysis demonstrated that ΔCT-FFR had the highest predictive accuracy for ISR, with an AUC of 0.923 (95% CI: 0.889-0.957). Several clinical prediction models were developed, among which Model 3 displayed the highest predictive performance (AUC: 0.958, 95% CI, 0.932-0.984). A statistically significant difference was observed between Model 1 and Model 2 (AUC: 0.925 vs 0.950, P < 0.05). However, no significant difference was found between Model 1 and Model 3 (AUC: 0.925 vs 0.928, P > 0.05).

Conclusion: ΔCT-FFR and peri-stent FAI, as independent predictors of ISR after PCI in patients with coronary heart disease, have a high predictive value for ISR. In addition, the FAI around the stent has incremental value for CT-FFR. It is worth noting that, compared with clinical data, imaging features show higher predictive value.

目的:探讨基于冠状动脉CT血管造影(CCTA)的CT分数血流储备(CT- ffr)和脂肪衰减指数(FAI)对冠心病患者PCI术后支架内再狭窄(ISR)的预测价值。方法:回顾性收集冠状动脉支架植入术后随访的冠心病患者,记录其临床资料、支架特征及影像学特征。采用Spearman检验分析CT-FFR、FAI与ISR的相关性。采用单因素和多因素logistic回归分析确定影响ISR的独立因素,并构建nomogram模型。结果:最终纳入378例患者。其中,ISR组120例,非ISR组258例。多因素分析显示,CT-FFR2cm、ΔCT-FFR、FAIlesion、支架长度、ΔCT-FFR/长度、高脂血症和脂蛋白(a)是ISR的独立预测因素。ROC分析显示ΔCT-FFR对ISR的预测准确率最高,AUC为0.923 (95% CI: 0.889-0.957)。建立了几种临床预测模型,其中模型3的预测性能最高(AUC: 0.958, 95% CI: 0.932 ~ 0.984)。模型1与模型2比较,差异有统计学意义(AUC: 0.925 vs 0.950, P < 0.05)。但模型1与模型3之间无显著差异(AUC: 0.925 vs 0.928, P < 0.05)。结论:ΔCT-FFR和支架周围FAI作为冠心病患者PCI术后ISR的独立预测因子,对ISR具有较高的预测价值。此外,支架周围FAI对CT-FFR有增加价值。值得注意的是,与临床资料相比,影像学表现具有更高的预测价值。
{"title":"Predictive Value of CT Fractional Flow Reserve and Fat Attenuation Index Derived from Coronary CT Angiography for In-Stent Restenosis After Percutaneous Coronary Intervention.","authors":"Beibei Li, Zhiguo Zhang, Xianglei Wei, Tianzeng Song, Yi Zhao, Wei Wang","doi":"10.2147/TCRM.S554207","DOIUrl":"10.2147/TCRM.S554207","url":null,"abstract":"<p><strong>Aim: </strong>To investigate the predictive value of CT fractional flow reserve (CT-FFR) and fat attenuation index (FAI) based on Coronary CT Angiography (CCTA) for in-stent restenosis (ISR) in patients with CAD after PCI.</p><p><strong>Methods: </strong>Patients with coronary heart disease who were followed up after coronary stent implantation were retrospectively collected, and clinical data, stent features and imaging characteristics were recorded. The Spearman test was used to analyze the correlation between CT-FFR, FAI and ISR. Univariate and multivariate logistic regression were used to determine the independent influencing factors of ISR, and a nomogram model was constructed.</p><p><strong>Results: </strong>A total of 378 patients were ultimately included. Among them, there were 120 cases in the ISR group and 258 cases in the non-ISR group. Multivariate analysis revealed that CT-FFR<sub>2cm</sub>, ΔCT-FFR, FAI<sub>lesion</sub>, stent length, ΔCT-FFR/length, hyperlipidemia, and lipoprotein(a) are independent predictors of ISR. The ROC analysis demonstrated that ΔCT-FFR had the highest predictive accuracy for ISR, with an AUC of 0.923 (95% CI: 0.889-0.957). Several clinical prediction models were developed, among which Model 3 displayed the highest predictive performance (AUC: 0.958, 95% CI, 0.932-0.984). A statistically significant difference was observed between Model 1 and Model 2 (AUC: 0.925 vs 0.950, P < 0.05). However, no significant difference was found between Model 1 and Model 3 (AUC: 0.925 vs 0.928, P > 0.05).</p><p><strong>Conclusion: </strong>ΔCT-FFR and peri-stent FAI, as independent predictors of ISR after PCI in patients with coronary heart disease, have a high predictive value for ISR. In addition, the FAI around the stent has incremental value for CT-FFR. It is worth noting that, compared with clinical data, imaging features show higher predictive value.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1535-1548"},"PeriodicalIF":2.8,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Serum Cholinesterase with Contrast-Associated Acute Kidney Injury and Adverse Outcomes in Percutaneous Coronary Intervention Patients. 经皮冠状动脉介入治疗患者血清胆碱酯酶与造影剂相关急性肾损伤及不良结局的关系
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-10-24 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S514823
Li-Wei Zhang, Ji-Lang Zeng, Chang-Xi Wang, Man-Qing Luo, Kai-Yang Lin, Yansong Guo

Purpose: Serum cholinesterase (SChE) is a pleiotropic biomarker that is closely related to malnutrition, systemic inflammation, and hepatocyte injury. However, the utility of SChE in patients undergoing percutaneous coronary intervention (PCI) remains unclear. This study sought to investigate the associations between SChE and contrast-associated acute kidney injury (CA-AKI) as well as mortality in patients undergoing PCI.

Patients and methods: We retrospectively observed 1,696 patients at a tertiary hospital from January 2016 to December 2018. CA-AKI was defined as an increase in serum creatinine ≥50% or 0.3 mg/dL within 48 h after contrast medium exposure.

Results: During hospitalization, 198 patients (11.7%) developed CA-AKI. Restricted cubic spline (RCS) and receiver operating characteristic (ROC) analysis demonstrated that SChE levels were negatively correlated with CA-AKI and had predictive value (AUC, 0.655; 95% CI, 0.613-0.697). Multivariable regression analysis showed that patients in low-SChE group (≤7.5 kU/L) had a higher risk of developing CA-AKI (OR, 1.80; 95% CI, 1.21-2.67) compared to those in the high-SChE group (>7.5 kU/L). Regarding prognosis, SChE levels were also negatively associated with long-term mortality and were capable of predicting 90-day mortality (AUC, 0.826; 95% CI, 0.760-0.892). Patients in the low-SChE group had significantly higher long-term mortality risks (HR, 2.56; 95% CI, 1.55-4.32). Mediation analyses further indicated that CA-AKI partially mediated the relationship between SChE and short-term mortality, with a mediation proportion of 12.79%.

Conclusion: Low SChE is an independent risk factor for CA-AKI and a poor prognosis after PCI. Short-term mortality associated with SChE levels is partially mediated through the occurrence of CA-AKI. It is recommended that clinicians evaluate SChE levels prior to PCI and adjust hydration therapy according to SChE levels.

目的:血清胆碱酯酶(SChE)是一种多效性生物标志物,与营养不良、全身性炎症和肝细胞损伤密切相关。然而,SChE在经皮冠状动脉介入治疗(PCI)患者中的应用尚不清楚。本研究旨在探讨行PCI的患者的SChE与造影剂相关性急性肾损伤(CA-AKI)以及死亡率之间的关系。患者和方法:我们回顾性观察了2016年1月至2018年12月在某三级医院就诊的1696例患者。CA-AKI定义为造影剂暴露后48小时内血清肌酐升高≥50%或0.3 mg/dL。结果:住院期间发生CA-AKI 198例(11.7%)。限制性三次样条(RCS)和受试者工作特征(ROC)分析显示,SChE水平与CA-AKI呈负相关,具有预测价值(AUC, 0.655; 95% CI, 0.613-0.697)。多变量回归分析显示,低sche组(≤7.5 kU/L)患者发生CA-AKI的风险高于高sche组(≤7.5 kU/L) (OR, 1.80; 95% CI, 1.21-2.67)。关于预后,SChE水平也与长期死亡率呈负相关,能够预测90天死亡率(AUC, 0.826; 95% CI, 0.760-0.892)。低sche组患者的长期死亡风险显著较高(HR, 2.56; 95% CI, 1.55-4.32)。进一步的中介分析表明,CA-AKI部分介导了SChE与短期死亡率的关系,中介比例为12.79%。结论:低SChE是CA-AKI和PCI术后不良预后的独立危险因素。与SChE水平相关的短期死亡率部分通过CA-AKI的发生介导。建议临床医生在PCI前评估SChE水平,并根据SChE水平调整水化治疗。
{"title":"Association of Serum Cholinesterase with Contrast-Associated Acute Kidney Injury and Adverse Outcomes in Percutaneous Coronary Intervention Patients.","authors":"Li-Wei Zhang, Ji-Lang Zeng, Chang-Xi Wang, Man-Qing Luo, Kai-Yang Lin, Yansong Guo","doi":"10.2147/TCRM.S514823","DOIUrl":"10.2147/TCRM.S514823","url":null,"abstract":"<p><strong>Purpose: </strong>Serum cholinesterase (SChE) is a pleiotropic biomarker that is closely related to malnutrition, systemic inflammation, and hepatocyte injury. However, the utility of SChE in patients undergoing percutaneous coronary intervention (PCI) remains unclear. This study sought to investigate the associations between SChE and contrast-associated acute kidney injury (CA-AKI) as well as mortality in patients undergoing PCI.</p><p><strong>Patients and methods: </strong>We retrospectively observed 1,696 patients at a tertiary hospital from January 2016 to December 2018. CA-AKI was defined as an increase in serum creatinine ≥50% or 0.3 mg/dL within 48 h after contrast medium exposure.</p><p><strong>Results: </strong>During hospitalization, 198 patients (11.7%) developed CA-AKI. Restricted cubic spline (RCS) and receiver operating characteristic (ROC) analysis demonstrated that SChE levels were negatively correlated with CA-AKI and had predictive value (AUC, 0.655; 95% CI, 0.613-0.697). Multivariable regression analysis showed that patients in low-SChE group (≤7.5 kU/L) had a higher risk of developing CA-AKI (OR, 1.80; 95% CI, 1.21-2.67) compared to those in the high-SChE group (>7.5 kU/L). Regarding prognosis, SChE levels were also negatively associated with long-term mortality and were capable of predicting 90-day mortality (AUC, 0.826; 95% CI, 0.760-0.892). Patients in the low-SChE group had significantly higher long-term mortality risks (HR, 2.56; 95% CI, 1.55-4.32). Mediation analyses further indicated that CA-AKI partially mediated the relationship between SChE and short-term mortality, with a mediation proportion of 12.79%.</p><p><strong>Conclusion: </strong>Low SChE is an independent risk factor for CA-AKI and a poor prognosis after PCI. Short-term mortality associated with SChE levels is partially mediated through the occurrence of CA-AKI. It is recommended that clinicians evaluate SChE levels prior to PCI and adjust hydration therapy according to SChE levels.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1499-1508"},"PeriodicalIF":2.8,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12561597/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145402050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Neurofactor Changes and Prognosis in Elderly Patients with Spontaneous Intracerebral Hemorrhage Treated with Endoscopic versus Conventional Craniotomy Surgery. 内窥镜与常规开颅手术治疗老年自发性脑出血患者神经因子变化及预后的比较。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-10-24 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S521299
Chao Lei, Chong Li, Xing Chen, Gaosheng Zhou, Xiaxia Zheng, Zhaohui Zhang, Xingguang Qu

Objective: To compare the clinical efficacy, neurofactor changes, and prognosis in elderly patients with spontaneous intracerebral hemorrhage (ICH) treated with endoscopic surgery versus conventional craniotomy.

Methods: A retrospective analysis was conducted on 88 elderly patients with spontaneous ICH admitted from July 2021 to April 2024. Based on surgical method, patients were assigned to either the conventional craniotomy group (n=44) or the endoscopic surgery group (n=44). Surgical efficacy (hematoma evacuation rate, surgical duration, intraoperative blood loss), short-term prognosis (ICU stay, hospital stay, GOS, NIHSS, ADL scores), serum neurofactors (SOD, NSE, NGF, BDNF), inflammatory markers (WBC, CRP, PCT), and complication rates were compared.

Results: (1) The endoscopic group had significantly shorter surgical time and lower blood loss than the craniotomy group (P<0.05), with similar hematoma evacuation rates (P>0.05). (2) ICU and hospital stays were significantly shorter in the endoscopic group (P<0.05). Postoperative GOS and ADL scores were higher, and NIHSS scores were lower in the endoscopic group at 3 months (P<0.05). (3) Compared with preoperative levels, both groups showed a decreasing trend in SOD and NSE and an increasing trend in NGF and BDNF after surgery, with the observation group showing more significant and sustained changes over time (P < 0.05). (4) Although postoperative inflammatory markers increased in both groups, the observation group had milder elevations and faster downward trends (P < 0.05). (5) The complication rate was lower in the endoscopic group (6.82% vs 22.73%, P<0.05).

Conclusion: Compared to conventional craniotomy, endoscopic hematoma evacuation in elderly ICH patients results in milder inflammatory responses, more favorable neurofactor changes, fewer complications, and improved recovery. However, these findings require further validation due to the retrospective design and limited sample size.

目的:比较内窥镜手术与常规开颅术治疗老年自发性脑出血(ICH)的临床疗效、神经因子变化及预后。方法:对我院2021年7月至2024年4月收治的88例老年自发性脑出血患者进行回顾性分析。根据手术方式将患者分为常规开颅组(n=44)和内镜手术组(n=44)。比较手术疗效(血肿排出率、手术时间、术中出血量)、短期预后(ICU住院时间、住院时间、GOS、NIHSS、ADL评分)、血清神经因子(SOD、NSE、NGF、BDNF)、炎症标志物(WBC、CRP、PCT)、并发症发生率。结果:(1)内镜组手术时间明显短于开颅组,出血量明显低于开颅组(P0.05)。(2)内镜组ICU和住院时间明显缩短(p)结论:与常规开颅术相比,内镜下血肿引流老年脑出血患者炎症反应较轻,神经因子变化更有利,并发症更少,恢复更快。然而,由于回顾性设计和有限的样本量,这些发现需要进一步验证。
{"title":"Comparison of Neurofactor Changes and Prognosis in Elderly Patients with Spontaneous Intracerebral Hemorrhage Treated with Endoscopic versus Conventional Craniotomy Surgery.","authors":"Chao Lei, Chong Li, Xing Chen, Gaosheng Zhou, Xiaxia Zheng, Zhaohui Zhang, Xingguang Qu","doi":"10.2147/TCRM.S521299","DOIUrl":"10.2147/TCRM.S521299","url":null,"abstract":"<p><strong>Objective: </strong>To compare the clinical efficacy, neurofactor changes, and prognosis in elderly patients with spontaneous intracerebral hemorrhage (ICH) treated with endoscopic surgery versus conventional craniotomy.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 88 elderly patients with spontaneous ICH admitted from July 2021 to April 2024. Based on surgical method, patients were assigned to either the conventional craniotomy group (n=44) or the endoscopic surgery group (n=44). Surgical efficacy (hematoma evacuation rate, surgical duration, intraoperative blood loss), short-term prognosis (ICU stay, hospital stay, GOS, NIHSS, ADL scores), serum neurofactors (SOD, NSE, NGF, BDNF), inflammatory markers (WBC, CRP, PCT), and complication rates were compared.</p><p><strong>Results: </strong>(1) The endoscopic group had significantly shorter surgical time and lower blood loss than the craniotomy group (P<0.05), with similar hematoma evacuation rates (P>0.05). (2) ICU and hospital stays were significantly shorter in the endoscopic group (P<0.05). Postoperative GOS and ADL scores were higher, and NIHSS scores were lower in the endoscopic group at 3 months (P<0.05). (3) Compared with preoperative levels, both groups showed a decreasing trend in SOD and NSE and an increasing trend in NGF and BDNF after surgery, with the observation group showing more significant and sustained changes over time (P < 0.05). (4) Although postoperative inflammatory markers increased in both groups, the observation group had milder elevations and faster downward trends (P < 0.05). (5) The complication rate was lower in the endoscopic group (6.82% vs 22.73%, P<0.05).</p><p><strong>Conclusion: </strong>Compared to conventional craniotomy, endoscopic hematoma evacuation in elderly ICH patients results in milder inflammatory responses, more favorable neurofactor changes, fewer complications, and improved recovery. However, these findings require further validation due to the retrospective design and limited sample size.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1509-1519"},"PeriodicalIF":2.8,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12561632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145402066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Induced Hypothermia on Postoperative Outcomes Following Hyperthermic Intraperitoneal Chemotherapy: A Negative Finding. 诱导低温对腹腔内高温化疗后术后预后的影响:一个阴性发现。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-10-22 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S551927
Ming-Chi Yang, Kai-Lieh Lin, Kuan-Chih Chung, Sheng-En Chou, Min Chien, Chih-Yi Hsu

Purpose: The optimal strategy for body temperature management during cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) remains controversial. This study aimed to assess whether intentionally cooling the core body temperature (CBT) to hypothermia (<35°C) before the HIPEC phase improves postoperative outcomes.

Patients and methods: In this retrospective cohort study, we analyzed 73 patients who underwent CRS plus HIPEC, grouped by CBT immediately before HIPEC: CBT ≥ 35°C (n=51) and CBT < 35°C (n=22). Primary outcomes including time to extubation and Clavien-Dindo classification. Secondary outcomes including length of stay (LOS), ICU stay, postoperative acute kidney injury (AKI) and reintubation event. Intraoperative parameters such as hemodynamic status, blood loss, transfusion requirements, and intravenous (IV) fluid amount were also compared.

Results: Compared to the normothermia group, patients in the hypothermia group had significantly longer time to extubation (median 11.5 vs 8.0 hours, p = 0.0314), greater blood loss (median 350 vs 150 mL, p = 0.0045), higher leukocyte-poor red blood cells transfusion units (p = 0.0016) and increased total IV fluid amount (p = 0.0049). Delayed extubation, defined as occurring more than 12 hours after surgery, appeared to be independently associated with hypothermia (odds ratio [OR] 6.31, 95% confidence interval [CI] 1.11-35.70, P = 0.037) and total IV fluid administration (per 100 mL; OR 1.05, 95% CI 1.00-1.10, P = 0.042) in multivariate analysis.

Conclusion: Actively inducing hypothermia before the HIPEC phase did not demonstrate improved postoperative outcomes and may be associated with delayed extubation, greater blood loss, higher transfusion requirements, and increased IV fluid administration.

目的:在细胞减少手术(CRS)与腹腔热化疗(HIPEC)期间,体温管理的最佳策略仍然存在争议。本研究旨在评估是否有意降低核心体温(CBT)至低温(患者和方法:在这项回顾性队列研究中,我们分析了73例接受CRS + HIPEC的患者,根据HIPEC前的CBT分组:CBT≥35°C(51例)和CBT < 35°C(22例)。主要结局包括拔管时间和Clavien-Dindo分级。次要结局包括住院时间(LOS)、ICU住院时间、术后急性肾损伤(AKI)和再插管事件。术中参数如血流动力学状态、出血量、输血要求和静脉(IV)液量也进行了比较。结果:与常温组相比,低温组患者拔管时间明显延长(中位数11.5小时vs 8.0小时,p = 0.0314),出血量明显增加(中位数350 mL vs 150 mL, p = 0.0045),白细胞差红细胞输血单位增加(p = 0.0016),总静脉输液量增加(p = 0.0049)。延迟拔管,定义为术后超过12小时,在多因素分析中似乎与低温(优势比[OR] 6.31, 95%可信区间[CI] 1.11-35.70, P = 0.037)和总静脉输液(每100 mL; OR 1.05, 95% CI 1.00-1.10, P = 0.042)独立相关。结论:在HIPEC期之前积极诱导低温并不能改善术后结果,而且可能与拔管延迟、出血量增加、输血需求增加和静脉输液增加有关。
{"title":"The Effect of Induced Hypothermia on Postoperative Outcomes Following Hyperthermic Intraperitoneal Chemotherapy: A Negative Finding.","authors":"Ming-Chi Yang, Kai-Lieh Lin, Kuan-Chih Chung, Sheng-En Chou, Min Chien, Chih-Yi Hsu","doi":"10.2147/TCRM.S551927","DOIUrl":"10.2147/TCRM.S551927","url":null,"abstract":"<p><strong>Purpose: </strong>The optimal strategy for body temperature management during cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) remains controversial. This study aimed to assess whether intentionally cooling the core body temperature (CBT) to hypothermia (<35°C) before the HIPEC phase improves postoperative outcomes.</p><p><strong>Patients and methods: </strong>In this retrospective cohort study, we analyzed 73 patients who underwent CRS plus HIPEC, grouped by CBT immediately before HIPEC: CBT ≥ 35°C (n=51) and CBT < 35°C (n=22). Primary outcomes including time to extubation and Clavien-Dindo classification. Secondary outcomes including length of stay (LOS), ICU stay, postoperative acute kidney injury (AKI) and reintubation event. Intraoperative parameters such as hemodynamic status, blood loss, transfusion requirements, and intravenous (IV) fluid amount were also compared.</p><p><strong>Results: </strong>Compared to the normothermia group, patients in the hypothermia group had significantly longer time to extubation (median 11.5 vs 8.0 hours, p = 0.0314), greater blood loss (median 350 vs 150 mL, p = 0.0045), higher leukocyte-poor red blood cells transfusion units (p = 0.0016) and increased total IV fluid amount (p = 0.0049). Delayed extubation, defined as occurring more than 12 hours after surgery, appeared to be independently associated with hypothermia (odds ratio [OR] 6.31, 95% confidence interval [CI] 1.11-35.70, <i>P</i> = 0.037) and total IV fluid administration (per 100 mL; OR 1.05, 95% CI 1.00-1.10, <i>P</i> = 0.042) in multivariate analysis.</p><p><strong>Conclusion: </strong>Actively inducing hypothermia before the HIPEC phase did not demonstrate improved postoperative outcomes and may be associated with delayed extubation, greater blood loss, higher transfusion requirements, and increased IV fluid administration.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1485-1498"},"PeriodicalIF":2.8,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12554287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145378906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Risk Assessment of Lateral Position Endotracheal Intubation Combined with Airway Surface Anesthesia in Gastrointestinal Endoscopic Surgery: A Randomized Controlled Non-Inferiority Study. 侧卧位气管插管联合气道表面麻醉在胃肠道内镜手术中的疗效和风险评估:一项随机对照非劣效性研究。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S541144
Li Tang, Jiehao Huang, Jinxin Guo, Mu Zhang, Wei Chen, Xiaoyong Zhao, Rui Xia, Wei Xu

Purpose: This study aims to evaluate and compare the efficacy and safety of endotracheal intubation in the lateral versus supine position, with both approaches combined with airway surface anesthesia, in patients undergoing gastrointestinal endoscopic surgery.

Patients and methods: A total of 128 patients undergoing gastrointestinal endoscopic surgery under general anesthesia with intubation were randomized into a lateral (L, n=64) or supine (S, n=64) intubation group, both receiving airway surface anesthesia, between January and March 2025. The primary outcome measure was intubation time, while secondary outcomes included changes in intraoperative vital signs, number of intubation attempts, first-pass success rate, positioning time, healthcare worker satisfaction, and postoperative complications.

Results: No significant differences were found between the two groups in terms of age, sex, height, weight, BMI, ASA classification, and airway assessment (P > 0.05). Mean intubation times differed slightly between groups (S group: 37.4±7.6s, 95% CI 35.5-39.3; L group: 40.1±8.5s, 95% CI 38.0-42.2). The non-inferiority margin (δ) for this study was 6s, and the upper limit of the L group's confidence interval (42.2s) was below the threshold of 39.3 + 6s. Thus, lateral position intubation was not inferior to supine intubation in terms of intubation time. There were no significant differences between the groups in the number of intubation attempts or first-pass success rate (P > 0.05). However, during positioning, the S group experienced greater hemodynamic fluctuations and a longer positioning time compared to the L group, and these differences were statistically significant (P < 0.05). Neither group showed any dental injuries or hypoxemia, and there were no significant differences in adverse reactions between the groups (P > 0.05).

Conclusion: Compared with conventional supine intubation, lateral position endotracheal intubation with airway surface anesthesia achieves similar efficacy while providing better hemodynamic stability, faster positioning, and higher provider satisfaction.

目的:本研究旨在评价和比较侧卧位与仰卧位气管插管联合气道表面麻醉在胃肠内镜手术患者中的疗效和安全性。患者和方法:选取2025年1 - 3月行胃肠内镜手术全麻插管患者128例,随机分为侧卧(L, n=64)和仰卧(S, n=64)插管组,均采用气道表面麻醉。主要结局指标为插管时间,次要结局指标包括术中生命体征变化、插管次数、首次通过成功率、定位时间、医护人员满意度和术后并发症。结果:两组患者在年龄、性别、身高、体重、BMI、ASA分级、气道评估等方面差异无统计学意义(P < 0.05)。各组平均插管时间差异较小(S组:37.4±7.6s, 95% CI 35.5 ~ 39.3; L组:40.1±8.5s, 95% CI 38.0 ~ 42.2)。本研究的非劣效裕度(δ)为6s, L组置信区间上限(422 s)低于阈值39.3 + 6s。因此,在插管时间方面,侧卧位插管并不亚于仰卧位插管。两组间插管次数及首次成功率比较,差异均无统计学意义(P < 0.05)。但体位时,S组血流动力学波动较大,体位时间较L组长,差异有统计学意义(P < 0.05)。两组患者均未出现牙损伤或低氧血症,不良反应发生率组间比较差异无统计学意义(P < 0.05)。结论:与常规仰卧位气管插管相比,气道表面麻醉侧位气管插管疗效相近,且血流动力学稳定性更好,定位速度更快,提供者满意度更高。
{"title":"Efficacy and Risk Assessment of Lateral Position Endotracheal Intubation Combined with Airway Surface Anesthesia in Gastrointestinal Endoscopic Surgery: A Randomized Controlled Non-Inferiority Study.","authors":"Li Tang, Jiehao Huang, Jinxin Guo, Mu Zhang, Wei Chen, Xiaoyong Zhao, Rui Xia, Wei Xu","doi":"10.2147/TCRM.S541144","DOIUrl":"10.2147/TCRM.S541144","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to evaluate and compare the efficacy and safety of endotracheal intubation in the lateral versus supine position, with both approaches combined with airway surface anesthesia, in patients undergoing gastrointestinal endoscopic surgery.</p><p><strong>Patients and methods: </strong>A total of 128 patients undergoing gastrointestinal endoscopic surgery under general anesthesia with intubation were randomized into a lateral (L, n=64) or supine (S, n=64) intubation group, both receiving airway surface anesthesia, between January and March 2025. The primary outcome measure was intubation time, while secondary outcomes included changes in intraoperative vital signs, number of intubation attempts, first-pass success rate, positioning time, healthcare worker satisfaction, and postoperative complications.</p><p><strong>Results: </strong>No significant differences were found between the two groups in terms of age, sex, height, weight, BMI, ASA classification, and airway assessment (<i>P</i> > 0.05). Mean intubation times differed slightly between groups (S group: 37.4±7.6s, 95% CI 35.5-39.3; L group: 40.1±8.5s, 95% CI 38.0-42.2). The non-inferiority margin (δ) for this study was 6s, and the upper limit of the L group's confidence interval (42.2s) was below the threshold of 39.3 + 6s. Thus, lateral position intubation was not inferior to supine intubation in terms of intubation time. There were no significant differences between the groups in the number of intubation attempts or first-pass success rate (<i>P</i> > 0.05). However, during positioning, the S group experienced greater hemodynamic fluctuations and a longer positioning time compared to the L group, and these differences were statistically significant (<i>P</i> < 0.05). Neither group showed any dental injuries or hypoxemia, and there were no significant differences in adverse reactions between the groups (<i>P</i> > 0.05).</p><p><strong>Conclusion: </strong>Compared with conventional supine intubation, lateral position endotracheal intubation with airway surface anesthesia achieves similar efficacy while providing better hemodynamic stability, faster positioning, and higher provider satisfaction.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1473-1483"},"PeriodicalIF":2.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12535703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145337594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced Long-Term Survival After Postoperative Complications in Major Gastrointestinal Surgery. 降低大胃肠手术术后并发症后的长期生存率。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-10-11 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S543913
Daantje N Gratama, Laurence Weinberg, Nattaya Raykateeraroj, Je Min A Suh, Junyan Zhao, Elizabeth P Hu, Vidhura Ratnasekara, Thomas Freeman, David S Liu, Alexandre Joosten, Vijayaragavan Muralidharan, Mehrdad Nikfarjam, Dong-Kyu Lee

Purpose: We primarily evaluated the relationship between postoperative complications and long-term survival in patients undergoing major gastrointestinal surgery. Secondarily, we investigated the relationship between the severity and the number of complications and long-term survival. While postoperative complications are prevalent after major abdominal surgery and associated with increased mortality, the effect of their severity and accumulation remains insufficiently explored.

Patients and methods: 1989 adult patients undergoing major gastrointestinal surgery between July 2010 and April 2022 were retrospectively studied. Complications were classified using the Clavien-Dindo system. Kaplan-Meier analysis assessed long-term survival, Cox proportional hazards regression with time-dependent coefficients evaluated the impact of complications on mortality.

Results: Median age was 64 years (IQR 53-74); 41.8% female and 63.0% of patients were diagnosed with malignancy. Elective procedures comprised 73.0% of cases. Complications occurred in 74.6% of patients. Mortality was higher in patients with complications (32.0%, 95% CI 29.7%-34.5%), compared to those without (21.7%, 95% CI 18.3-25.6%; P<0.001). Severe complications (Clavien-Dindo Grade ≥III) were associated with a 15.01-fold higher hazard of mortality within 18 months postoperatively (95% CI 6.83-33.0; P<0.001).

Conclusion: Postoperative complications significantly reduce long-term survival following major gastrointestinal surgery. Both their severity and frequency are critical determinants of poorer outcomes, emphasizing the need for effective prevention strategies.

目的:我们主要评估胃肠大手术患者术后并发症与长期生存的关系。其次,我们调查了并发症的严重程度和数量与长期生存的关系。虽然术后并发症在腹部大手术后很普遍,并与死亡率增加有关,但其严重程度和积累的影响仍未得到充分探讨。患者与方法:对2010年7月至2022年4月期间接受胃肠大手术的1989例成人患者进行回顾性研究。采用Clavien-Dindo系统对并发症进行分类。Kaplan-Meier分析评估长期生存率,Cox时间相关系数比例风险回归评估并发症对死亡率的影响。结果:中位年龄64岁(IQR 53 ~ 74);女性占41.8%,恶性肿瘤占63.0%。选择性手术占73.0%。74.6%的患者出现并发症。有并发症患者的死亡率(32.0%,95% CI 29.7%-34.5%)高于无并发症患者(21.7%,95% CI 18.3-25.6%)。结论:术后并发症显著降低胃肠道大手术后的长期生存率。其严重程度和频率都是较差结果的关键决定因素,强调需要有效的预防战略。
{"title":"Reduced Long-Term Survival After Postoperative Complications in Major Gastrointestinal Surgery.","authors":"Daantje N Gratama, Laurence Weinberg, Nattaya Raykateeraroj, Je Min A Suh, Junyan Zhao, Elizabeth P Hu, Vidhura Ratnasekara, Thomas Freeman, David S Liu, Alexandre Joosten, Vijayaragavan Muralidharan, Mehrdad Nikfarjam, Dong-Kyu Lee","doi":"10.2147/TCRM.S543913","DOIUrl":"10.2147/TCRM.S543913","url":null,"abstract":"<p><strong>Purpose: </strong>We primarily evaluated the relationship between postoperative complications and long-term survival in patients undergoing major gastrointestinal surgery. Secondarily, we investigated the relationship between the severity and the number of complications and long-term survival. While postoperative complications are prevalent after major abdominal surgery and associated with increased mortality, the effect of their severity and accumulation remains insufficiently explored.</p><p><strong>Patients and methods: </strong>1989 adult patients undergoing major gastrointestinal surgery between July 2010 and April 2022 were retrospectively studied. Complications were classified using the Clavien-Dindo system. Kaplan-Meier analysis assessed long-term survival, Cox proportional hazards regression with time-dependent coefficients evaluated the impact of complications on mortality.</p><p><strong>Results: </strong>Median age was 64 years (IQR 53-74); 41.8% female and 63.0% of patients were diagnosed with malignancy. Elective procedures comprised 73.0% of cases. Complications occurred in 74.6% of patients. Mortality was higher in patients with complications (32.0%, 95% CI 29.7%-34.5%), compared to those without (21.7%, 95% CI 18.3-25.6%; <i>P</i><0.001). Severe complications (Clavien-Dindo Grade ≥III) were associated with a 15.01-fold higher hazard of mortality within 18 months postoperatively (95% CI 6.83-33.0; <i>P</i><0.001).</p><p><strong>Conclusion: </strong>Postoperative complications significantly reduce long-term survival following major gastrointestinal surgery. Both their severity and frequency are critical determinants of poorer outcomes, emphasizing the need for effective prevention strategies.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1459-1472"},"PeriodicalIF":2.8,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523569/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Current Tools in Cardiovascular Risk Assessment in the Middle East and the Need for Region-Specific Models - A Scoping Review. 探索中东心血管风险评估的现有工具和对区域特定模型的需求-范围综述
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-10-10 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S520628
Gamilah Abdulkarem Al-Ezzi, Adliah Mhd Ali, Mohammed Abdullah Kubas, Adyani Md Redzuan

Background: Cardiovascular diseases (CVDs) are a major contributor to premature mortality, disability, and reduced quality of life globally. Assessing CVD risks is central to primary prevention, prompting the development of numerous tools to predict CVD risks for the general population. However, it is unclear which tools are recommended in clinical practice in the Middle East region.

Aim: This scoping review aims to identify, review, and summarize the available literature on CVD risk assessment tools recommended for the general population in the Middle East region.

Methods: The scoping review synthesized the literature on CVD risk assessment tools recommended for the general population in the Middle East region. It followed PRISMA-ScR guidelines, covering searches in the Web of Science (WOS), Medline, and Scopus databases. English-language articles published between 2015 and 2024 that focused on the primary prevention of CVDs in sixteen Middle Eastern countries were included.

Results: Seventeen articles met the inclusion criteria. The studies were distributed over Cyprus (n=1), Iran (n=7), Saudi Arabia (n=4), Qatar (n=1), the United Arab Emirates (n=3), and Egypt (n=1). Various tools are recommended in these countries, including validated Western tools such as ACC/AHA Pooled-Cohort Equations (PCE), Systematic Coronary Risk Evaluation 2 (SCORE 2), World Health Organization charts (WHO/ ISH) for the Eastern Mediterranean region (EMR), Cardiovascular Disease Risk Algorithm (QRISK3), and PREDICT. Some studies in Iran, Saudi Arabia, the United Arab Emirates, and Egypt focused on developing new CVD risk tools tailored for national use.

Conclusion: Current studies on CVD risk assessment are limited and have been conducted in six Middle Eastern countries. These studies recommend various tools, including both validated Western models and locally developed frameworks. However, the limitations of existing tools and the gaps in current research underscore the need for further studies to develop or recalibrate models that account for country-specific CVD risk factors across the region.

背景:心血管疾病(cvd)是全球过早死亡、残疾和生活质量下降的主要原因。评估心血管疾病风险是一级预防的核心,这促使开发了许多工具来预测普通人群的心血管疾病风险。然而,目前尚不清楚哪些工具在中东地区的临床实践中被推荐。目的:本综述旨在识别、回顾和总结中东地区推荐的心血管疾病风险评估工具的现有文献。方法:对中东地区一般人群推荐的心血管疾病风险评估工具的文献进行范围综述。它遵循PRISMA-ScR指南,涵盖了Web of Science (WOS)、Medline和Scopus数据库中的搜索。纳入了2015年至2024年间发表的英语文章,重点关注16个中东国家心血管疾病的初级预防。结果:17篇文章符合纳入标准。这些研究分布在塞浦路斯(n=1)、伊朗(n=7)、沙特阿拉伯(n=4)、卡塔尔(n=1)、阿拉伯联合酋长国(n=3)和埃及(n=1)。这些国家推荐使用各种工具,包括经过验证的西方工具,如ACC/AHA合并队列方程(PCE)、系统性冠状动脉风险评估2 (SCORE 2)、世界卫生组织东地中海地区(EMR)图表(WHO/ ISH)、心血管疾病风险算法(QRISK3)和PREDICT。在伊朗、沙特阿拉伯、阿拉伯联合酋长国和埃及进行的一些研究侧重于开发适合本国使用的新的心血管疾病风险工具。结论:目前关于心血管疾病风险评估的研究有限,仅在六个中东国家进行。这些研究推荐了各种工具,包括经过验证的西方模型和当地开发的框架。然而,现有工具的局限性和当前研究中的差距突出表明需要进一步研究,以开发或重新校准模型,以考虑整个区域特定国家的心血管疾病风险因素。
{"title":"Exploring the Current Tools in Cardiovascular Risk Assessment in the Middle East and the Need for Region-Specific Models - A Scoping Review.","authors":"Gamilah Abdulkarem Al-Ezzi, Adliah Mhd Ali, Mohammed Abdullah Kubas, Adyani Md Redzuan","doi":"10.2147/TCRM.S520628","DOIUrl":"10.2147/TCRM.S520628","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases (CVDs) are a major contributor to premature mortality, disability, and reduced quality of life globally. Assessing CVD risks is central to primary prevention, prompting the development of numerous tools to predict CVD risks for the general population. However, it is unclear which tools are recommended in clinical practice in the Middle East region.</p><p><strong>Aim: </strong>This scoping review aims to identify, review, and summarize the available literature on CVD risk assessment tools recommended for the general population in the Middle East region.</p><p><strong>Methods: </strong>The scoping review synthesized the literature on CVD risk assessment tools recommended for the general population in the Middle East region. It followed PRISMA-ScR guidelines, covering searches in the Web of Science (WOS), Medline, and Scopus databases. English-language articles published between 2015 and 2024 that focused on the primary prevention of CVDs in sixteen Middle Eastern countries were included.</p><p><strong>Results: </strong>Seventeen articles met the inclusion criteria. The studies were distributed over Cyprus (n=1), Iran (n=7), Saudi Arabia (n=4), Qatar (n=1), the United Arab Emirates (n=3), and Egypt (n=1). Various tools are recommended in these countries, including validated Western tools such as ACC/AHA Pooled-Cohort Equations (PCE), Systematic Coronary Risk Evaluation 2 (SCORE 2), World Health Organization charts (WHO/ ISH) for the Eastern Mediterranean region (EMR), Cardiovascular Disease Risk Algorithm (QRISK3), and PREDICT. Some studies in Iran, Saudi Arabia, the United Arab Emirates, and Egypt focused on developing new CVD risk tools tailored for national use.</p><p><strong>Conclusion: </strong>Current studies on CVD risk assessment are limited and have been conducted in six Middle Eastern countries. These studies recommend various tools, including both validated Western models and locally developed frameworks. However, the limitations of existing tools and the gaps in current research underscore the need for further studies to develop or recalibrate models that account for country-specific CVD risk factors across the region.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1443-1458"},"PeriodicalIF":2.8,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12519991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145303347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Incidence and Risk Factors for Dental Injury in Patients Undergoing General Anesthesia: A Case-Control Study. 全麻患者牙齿损伤的发生率及危险因素:一项病例-对照研究。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-10-09 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S552333
Sarinya Chanthawong, Saranyoo Nonphiaraj, Lady Vongtongchith, Nutrada Tisangka, Junjira Kaewaun, Peerapong Sangsungnern, Thitinuch Ruenhunsa, Laksanawadee Chairatana

Purpose: Dental injury is a known complication of endotracheal intubation during general anesthesia (GA), yet data on its incidence and associated risk factors remain limited. This study aimed to evaluate the incidence, risk factors, and outcomes of dental injury in patients undergoing GA.

Patients and methods: This retrospective case-control study was conducted between January 2021 and June 2024. A total of 42,826 patients underwent GA during the study period; 72 cases of dental injury were identified from the departmental database. Controls were time-matched patients who underwent surgery in the same anatomical region, using a case-to-control ratio of 1:4. Univariable and multivariable logistic regression analyses were performed to identify independent risk factors for dental injury.

Results: The incidence of dental injury was 0.17%. Univariate analysis identified the following factors as associated with dental injury: age ≥ 60 years, pre-existing dental pathology, Mallampati classification ≥ 3, anticipated difficult intubation, and difficult airway. In the multivariable logistic regression analysis, pre-existing dental pathology (adjusted OR 3.87, 95% CI: 1.92-7.81, p < 0.001), anticipated difficult intubation (adjusted OR 4.99, 95% CI: 1.84-13.50, p = 0.002), and difficult intubation (laryngoscopic view grade ≥ 3) (adjusted OR 10.56, 95% CI: 4.24-26.29, p < 0.001) remained significant independent predictors of dental injury during GA. The most common complication was bleeding.

Conclusion: Dental injury during GA is uncommon, with an incidence of 0.17%. Pre-existing dental pathology, anticipated difficult intubation, and poor laryngoscopic view (grade ≥ 3) were identified as independent risk factors. Awareness and thorough preoperative assessment of these factors may help reduce the risk of dental injury and related complications.

目的:牙齿损伤是全身麻醉(GA)期间气管插管的一种已知并发症,但其发生率和相关危险因素的数据仍然有限。本研究旨在评估GA患者牙损伤的发生率、危险因素和结果。患者和方法:该回顾性病例对照研究于2021年1月至2024年6月进行。在研究期间,共有42,826例患者接受了GA;从部门数据库中确定了72例牙齿损伤病例。对照组是在同一解剖区域接受手术的时间匹配的患者,病例与对照组的比例为1:4。进行单变量和多变量logistic回归分析,以确定牙齿损伤的独立危险因素。结果:牙损伤发生率为0.17%。单因素分析确定了以下因素与牙齿损伤相关:年龄≥60岁,先前存在的牙齿病理,Mallampati分类≥3,预期插管困难和气道困难。在多变量logistic回归分析中,预先存在的牙齿病理(调整后的OR为3.87,95% CI为1.92-7.81,p < 0.001)、预期插管困难(调整后的OR为4.99,95% CI为1.84-13.50,p = 0.002)和插管困难(喉镜检查分级≥3)(调整后的OR为10.56,95% CI为4.24-26.29,p < 0.001)仍然是GA期间牙齿损伤的重要独立预测因素。最常见的并发症是出血。结论:牙损伤发生率较低,为0.17%。先前存在的牙齿病理、预期插管困难和喉镜检查不佳(分级≥3)被确定为独立的危险因素。认识和全面的术前评估这些因素可能有助于减少牙齿损伤和相关并发症的风险。
{"title":"The Incidence and Risk Factors for Dental Injury in Patients Undergoing General Anesthesia: A Case-Control Study.","authors":"Sarinya Chanthawong, Saranyoo Nonphiaraj, Lady Vongtongchith, Nutrada Tisangka, Junjira Kaewaun, Peerapong Sangsungnern, Thitinuch Ruenhunsa, Laksanawadee Chairatana","doi":"10.2147/TCRM.S552333","DOIUrl":"10.2147/TCRM.S552333","url":null,"abstract":"<p><strong>Purpose: </strong>Dental injury is a known complication of endotracheal intubation during general anesthesia (GA), yet data on its incidence and associated risk factors remain limited. This study aimed to evaluate the incidence, risk factors, and outcomes of dental injury in patients undergoing GA.</p><p><strong>Patients and methods: </strong>This retrospective case-control study was conducted between January 2021 and June 2024. A total of 42,826 patients underwent GA during the study period; 72 cases of dental injury were identified from the departmental database. Controls were time-matched patients who underwent surgery in the same anatomical region, using a case-to-control ratio of 1:4. Univariable and multivariable logistic regression analyses were performed to identify independent risk factors for dental injury.</p><p><strong>Results: </strong>The incidence of dental injury was 0.17%. Univariate analysis identified the following factors as associated with dental injury: age ≥ 60 years, pre-existing dental pathology, Mallampati classification ≥ 3, anticipated difficult intubation, and difficult airway. In the multivariable logistic regression analysis, pre-existing dental pathology (adjusted OR 3.87, 95% CI: 1.92-7.81, p < 0.001), anticipated difficult intubation (adjusted OR 4.99, 95% CI: 1.84-13.50, p = 0.002), and difficult intubation (laryngoscopic view grade ≥ 3) (adjusted OR 10.56, 95% CI: 4.24-26.29, p < 0.001) remained significant independent predictors of dental injury during GA. The most common complication was bleeding.</p><p><strong>Conclusion: </strong>Dental injury during GA is uncommon, with an incidence of 0.17%. Pre-existing dental pathology, anticipated difficult intubation, and poor laryngoscopic view (grade ≥ 3) were identified as independent risk factors. Awareness and thorough preoperative assessment of these factors may help reduce the risk of dental injury and related complications.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1431-1441"},"PeriodicalIF":2.8,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12517181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutics and Clinical Risk Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1